Related Experiment Video

Updated: May 12, 2026

Isolation of Proximal Fluids to Investigate the Tumor Microenvironment of Pancreatic Adenocarcinoma
05:44

Isolation of Proximal Fluids to Investigate the Tumor Microenvironment of Pancreatic Adenocarcinoma

Published on: November 5, 2020

Enhanced expression of transforming growth factor beta isoforms in pancreatic cancer correlates with decreased

H Friess1, Y Yamanaka, M Büchler

  • 1Department of Medicine, University of California, Irvine.

Gastroenterology
|December 1, 1993
PubMed
Abstract

Insights

Human pancreatic cancers exhibit elevated levels of transforming growth factor beta (TGF-beta) isoforms and messenger RNA (mRNA). Increased TGF-beta expression in pancreatic tumors correlates with disease progression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Transforming growth factor beta (TGF-beta) are key regulators of cell proliferation, with dysregulation potentially driving cancer.
  • Altered TGF-beta signaling is implicated in various malignancies, necessitating investigation in pancreatic cancer.

Purpose of the Study:

  • To investigate the expression patterns of TGF-beta isoforms (TGF-beta 1, 2, and 3) in human pancreatic cancer.
  • To correlate TGF-beta expression with tumor stage and patient survival.

Main Methods:

  • Immunohistochemistry was used to detect TGF-beta protein distribution in 60 human pancreatic tumors.
  • Northern blot and in situ hybridization were employed to analyze TGF-beta mRNA expression levels and localization.

Main Results:

  • TGF-beta 1, 2, and 3 proteins were detected in 47%, 42%, and 40% of pancreatic tumors, respectively.
  • Elevated TGF-beta 2 levels were associated with advanced tumor stage.
  • Pancreatic adenocarcinomas showed significantly increased TGF-beta mRNA levels compared to normal pancreas tissue.
  • Absence of TGF-beta in tumors correlated with longer postoperative survival.

Conclusions:

  • Human pancreatic cancers demonstrate increased expression of TGF-beta isoforms at both protein and mRNA levels.
  • The presence of TGF-beta in pancreatic cancer cells may play a role in promoting disease progression.
  • Further research into TGF-beta targeted therapies for pancreatic cancer is warranted.

More Related Videos

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

Growing Desmoplastic Three-Dimensional Pancreatic Cancer Spheroids from Co-Culture03:42

Growing Desmoplastic Three-Dimensional Pancreatic Cancer Spheroids from Co-Culture

Published on: September 27, 2024

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...